Gene editing involves precise alterations to the genome, utilizing techniques such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the CRISPR/Cas9 system. Each method offers different efficiencies and complexities; CRISPR/Cas9 simplifies targeting by using RNA for precise cleavage, while ZFNs and TALENs involve more specialized design and higher costs. Advances such as base editing and dCas9 provide further capabilities for modifying DNA and epigenetic regulation.